CAS: 1421438-81-4
Butanamide, N-[(1S)-2-[[(7S)-6,7-dihydro-5-(2-hydroxyethyl)-6-oxo-5H-pyrido[3,2-a][3]benzazepin-7-yl]amino]-1-methyl-2-oxoethyl]-4,4,4-trifluoro-
CAS:1421438-81-4
Formula:
C22H23F3N4O4
Purity:
95%
Color and Shape:
Solid
Molecular weight:
464.4376
Ref: IN-DA001HUJ
5mg | 163.00 € | ||
10mg | 275.00 € | ||
25mg | 516.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Crenigacestat
CAS:1421438-81-4
Crenigacestat (LY3039478) is an orally bioavailable Notch inhibitor with an IC50 of ~1 nM in …
Formula:
C22H23F3N4O4
Purity:
97.27% - 98.76%
Color and Shape:
Solid
Molecular weight:
464.44
Ref: TM-T3633
1mg | 60.00 € | ||
5mg | 118.00 € | ||
10mg | 184.00 € | ||
25mg | 346.00 € | ||
50mg | To inquire | ||
1mL*10mM (DMSO) | 121.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
LY3039478
CAS:1421438-81-4
Inhibitor of NOTCH signalling
Formula:
C22H23F3N4O4
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
464.44 g/mol
Ref: 3D-FT76166
Undefined size | To inquire |
Estimated delivery in United States, on Monday 23 Dec 2024
LY 3039478
Controlled ProductCAS:1421438-81-4
Formula:
C22H23F3N4O4
Color and Shape:
Neat
Molecular weight:
464.438
Ref: TR-L468970
100mg | 17,769.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025